# Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA

> **NCT06525948** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 54 (estimated)

## Conditions studied

- Aplastic Anemia
- Transfusion-dependent Anemia

## Interventions

- **DRUG:** rhTPO
- **DRUG:** Cyclosporin A

## Key facts

- **NCT ID:** NCT06525948
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-07-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-30
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2024-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06525948

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06525948, "Efficacy and Safety of rhTPO in Combination With Cyclosporine Versus Cyclosporine Alone in the Treatment of TD-NSAA". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06525948. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*